JP2019519553A5 - - Google Patents

Download PDF

Info

Publication number
JP2019519553A5
JP2019519553A5 JP2018566519A JP2018566519A JP2019519553A5 JP 2019519553 A5 JP2019519553 A5 JP 2019519553A5 JP 2018566519 A JP2018566519 A JP 2018566519A JP 2018566519 A JP2018566519 A JP 2018566519A JP 2019519553 A5 JP2019519553 A5 JP 2019519553A5
Authority
JP
Japan
Prior art keywords
pinf
mutant
variant
seq
pig
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018566519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019519553A (ja
JP7093311B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/037964 external-priority patent/WO2017222940A1/en
Publication of JP2019519553A publication Critical patent/JP2019519553A/ja
Publication of JP2019519553A5 publication Critical patent/JP2019519553A5/ja
Priority to JP2022098147A priority Critical patent/JP7441892B2/ja
Application granted granted Critical
Publication of JP7093311B2 publication Critical patent/JP7093311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018566519A 2016-06-20 2017-06-16 ペグ化ブタインターフェロンおよびその使用方法 Active JP7093311B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022098147A JP7441892B2 (ja) 2016-06-20 2022-06-17 ペグ化ブタインターフェロンおよびその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662352163P 2016-06-20 2016-06-20
US62/352,163 2016-06-20
PCT/US2017/037964 WO2017222940A1 (en) 2016-06-20 2017-06-16 Pegylated porcine interferon and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022098147A Division JP7441892B2 (ja) 2016-06-20 2022-06-17 ペグ化ブタインターフェロンおよびその使用方法

Publications (3)

Publication Number Publication Date
JP2019519553A JP2019519553A (ja) 2019-07-11
JP2019519553A5 true JP2019519553A5 (enExample) 2020-01-30
JP7093311B2 JP7093311B2 (ja) 2022-06-29

Family

ID=59258379

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018566519A Active JP7093311B2 (ja) 2016-06-20 2017-06-16 ペグ化ブタインターフェロンおよびその使用方法
JP2022098147A Active JP7441892B2 (ja) 2016-06-20 2022-06-17 ペグ化ブタインターフェロンおよびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022098147A Active JP7441892B2 (ja) 2016-06-20 2022-06-17 ペグ化ブタインターフェロンおよびその使用方法

Country Status (17)

Country Link
US (2) US10960080B2 (enExample)
EP (1) EP3471755B1 (enExample)
JP (2) JP7093311B2 (enExample)
KR (2) KR102518451B1 (enExample)
CN (2) CN109641034B (enExample)
AU (2) AU2017280958A1 (enExample)
CA (1) CA3028683A1 (enExample)
CL (1) CL2018003697A1 (enExample)
DK (1) DK3471755T3 (enExample)
EA (1) EA036509B1 (enExample)
ES (1) ES2793773T3 (enExample)
MX (1) MX391970B (enExample)
NZ (1) NZ749962A (enExample)
PL (1) PL3471755T3 (enExample)
PT (1) PT3471755T (enExample)
WO (1) WO2017222940A1 (enExample)
ZA (1) ZA201808352B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170107216A1 (en) 2015-10-19 2017-04-20 Incyte Corporation Heterocyclic compounds as immunomodulators
MD3377488T2 (ro) 2015-11-19 2023-02-28 Incyte Corp Compuși heterociclici ca imunomodulatori
ES2916874T3 (es) 2015-12-17 2022-07-06 Incyte Corp Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
CA3009474A1 (en) 2015-12-22 2017-06-29 Incyte Corporation Heterocyclic compounds as immunomodulators
ES2906460T3 (es) 2016-05-06 2022-04-18 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
EP3464279B1 (en) 2016-05-26 2021-11-24 Incyte Corporation Heterocyclic compounds as immunomodulators
SG11201811414TA (en) 2016-06-20 2019-01-30 Incyte Corp Heterocyclic compounds as immunomodulators
MA45669A (fr) 2016-07-14 2019-05-22 Incyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
US20180057486A1 (en) 2016-08-29 2018-03-01 Incyte Corporation Heterocyclic compounds as immunomodulators
US10308644B2 (en) 2016-12-22 2019-06-04 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2018119236A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Triazolo[1,5-a]pyridine derivatives as immunomodulators
WO2018119286A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Bicyclic heteroaromatic compounds as immunomodulators
WO2018119221A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Pyridine derivatives as immunomodulators
EP4223369A1 (en) 2016-12-22 2023-08-09 Incyte Corporation Immunomodulator compounds and methods of use
SMT202300065T1 (it) 2018-03-30 2023-05-12 Incyte Corp Composti eterociclici come immunomodulatori
CN112752756B (zh) 2018-05-11 2024-06-25 因赛特公司 作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物
TW202115059A (zh) 2019-08-09 2021-04-16 美商英塞特公司 Pd—1/pd—l1抑制劑之鹽
CN110343164A (zh) * 2019-08-22 2019-10-18 安阳工学院 一种高活性7位点突变的猪干扰素α突变体及其制备方法和应用
JP7559059B2 (ja) 2019-09-30 2024-10-01 インサイト・コーポレイション 免疫調節剤としてのピリド[3,2-d]ピリミジン化合物
EP4058461A1 (en) 2019-11-11 2022-09-21 Incyte Corporation Salts and crystalline forms of a pd-1/pd-l1 inhibitor
IL302590A (en) 2020-11-06 2023-07-01 Incyte Corp Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
CN113845599B (zh) * 2021-11-01 2023-09-19 长春萤火虫生物科技有限公司 一种重组猪干扰素融合蛋白及其应用
WO2024241086A1 (en) 2023-05-24 2024-11-28 Ambrx, Inc. Pegylated bovine interferon lambda and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) * 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
HUT75533A (en) * 1993-11-10 1997-05-28 Schering Corp Improved interferon polymer conjugates
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US20050226845A1 (en) * 2004-03-10 2005-10-13 Chih-Ping Liu Method of treatment using interferon-tau
JP2006213597A (ja) 2000-07-19 2006-08-17 Pepgen Corp インターフェロン−タウを用いるc型肝炎ウイルスの処置のための組成物およびモニタリングの方法
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
KR20080026135A (ko) 2005-06-03 2008-03-24 암브룩스, 인코포레이티드 개선된 인간 인터페론 분자 및 이의 용도
US7695710B2 (en) * 2005-06-20 2010-04-13 Pepgen Corporation Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs
CN101883784B (zh) 2007-10-01 2014-10-15 药华医药股份有限公司 N-端修饰的干扰素-α
EP2318029B1 (en) 2008-07-23 2017-11-01 Ambrx, Inc. Modified bovine g-csf polypeptides and their uses
CN104262480B (zh) * 2014-09-28 2018-03-27 重庆理工大学 重组猪长效‑α干扰素的构建和修饰方法及其冻干注射剂的制备方法

Similar Documents

Publication Publication Date Title
JP7441892B2 (ja) ペグ化ブタインターフェロンおよびその使用方法
JP7795489B2 (ja) Tlrアゴニストによる呼吸器感染症の治療
EA019965B1 (ru) Комбинация ингибитора протеазы ns3 hcv с интерфероном и рибавирином
WO2014139359A1 (zh) 乙型肝炎疫苗
US20220023287A1 (en) Treatment of hepatitis delta virus infection
Liu et al. Interferon as a mucosal adjuvant for an influenza vaccine in pigs
JP2023517616A (ja) 急性呼吸窮迫症候群およびウイルス感染の治療用のcxcr4阻害剤
US8263562B2 (en) Peptides for preventing or treating liver damage
US20200276262A1 (en) Peptides for use in the treatment of viral infections
EP1797112B1 (en) Inhibitors of hepatitits c virus
US9872895B2 (en) TLR5 ligands, therapeutic methods, and compositions related thereto
JP2020518588A5 (enExample)
JP2014524450A5 (enExample)
JP2009515933A (ja) インフルエンザにおけるインターフェロン
JP2007537280A (ja) 免疫調節性化合物を用いる呼吸器のウイルス感染の治療又は予防
FANG et al. Prokaryotic Expression and Anti‑PRRSV Activity Study of Porcine IFN‑α8
EA008766B1 (ru) Интерферон-бета при тяжелом остром респираторном синдроме (sars)
US20230277650A1 (en) Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (vzv)
JPH02304100A (ja) ブタの肺炎または関連細菌病の予防または治療に使用するためのインターフェロン
Mohammed et al. Therapeutic challenges of COVID-19: strategies of empirical treatment
JPWO2004083186A1 (ja) ウイルス性肝炎治療剤及び制癌剤
HK1087358A (en) Interferon beta in severe acute respiratory syndrome (sars)